COVID-19 Rapidly Refocuses Attention on Telemedicine’s Enormous Opportunity COVID-19 continues to rapidly transform our society, it is becoming clearer every day that digital healthcare solutions like Telemedicine will be critical… Read more »
During our recent Medicate @ Intrepid event, we discussed how California’s top healthcare executives are responding to the COVID-19 coronavirus and how it is affecting their businesses, employees and clients. … Read more »
Intrepid was proud to sponsor and participate in the second annual Autism Investor Summit, which brought together many of the country’s fastest-growing autism services businesses with leading private equity investors… Read more »
2019 produced another record year for M&A activity in the fertility services sector as financial sponsors and strategic acquirers alike continued making moves to develop and consolidate the highly fragmented… Read more »
As we welcome in the New Year and a new decade, one constant remains in the healthcare industry – the deal community’s annual convergence in San Francisco’s Union Square each… Read more »
Join Us in Irvine for a Panel Discussion on Healthcare M&A Trends, Challenges, and Opportunities Intrepid’s Co-Head of Healthcare, Jonathan Bluth is speaking at the upcoming ACG SoCal Capital Summit…. Read more »
Intrepid’s Healthcare Group continues to see a high volume of consolidation activity across all segments of healthcare. An extraordinary breadth of strategic acquirers and financial sponsors are seeking M&A targets… Read more »
In July 2019, Exact Sciences (NASDAQ: EXAS) announced it would acquire Genomic Health (NASDAQ: GHDX) for $2.8 billion in cash and stock. This was one of the largest M&A deals… Read more »
Proud Sponsor of the 2019 ACG LA Business Conference Intrepid is proud to announce that for the 19th year in a row, we are a sponsor of the nation’s premier… Read more »
While hot sectors like ophthalmology, dermatology, genetics, and behavioral health continue to draw a lot of attention in the media, we are seeing an emerging group of middle-market private equity… Read more »
